Non-profit website: free to use. No fees from patients, hospitals or doctors. Not an agency. · Free · Not an agencyLearn more
Respiratory medicine · China-Japan Friendship Hospital · Beijing

Dr. Wu Xiaojing吴小静

Associate Chief Physician

Summary compiled from public information, updated 18 Nov 2026. It has not been checked against the hospital website yet. Confirm details with the hospital before you travel.

Dr. Wu Xiaojing

Professional overview

Wu Xiaojing is an Associate Chief Physician in the Department of Respiratory and Critical Care Medicine at China-Japan Friendship Hospital, with clinical expertise in respiratory infections, interstitial lung disease, chronic obstructive pulmonary disease (COPD), asthma, bronchiectasis, pulmonary nodules, and lung cancer.

SpecialtyRespiratory medicine
Clinical titleAssociate Chief Physician
Academic rolesMaster's Supervisor
DepartmentDepartment of Respiratory and Critical Care Medicine
HospitalChina-Japan Friendship Hospital
CityBeijing

Areas of focus

Pulmonary nodulesExpertise includes diagnosis and management of pulmonary nodules.
COPDExpertise includes diagnosis and management of chronic obstructive pulmonary disease.
AsthmaExpertise includes diagnosis and management of asthma.
BronchiectasisExpertise includes diagnosis and management of bronchiectasis.
Interstitial lung diseaseExpertise includes diagnosis and management of interstitial lung disease.
Lung cancerExpertise includes diagnosis and management of lung cancer.

Background

  • 2016Published on ventilator-induced lung injury and driving pressure in Zhonghua Yixue Zazhi (National Medical Journal of China).
  • 2017Published clinical analysis of six cases of pulmonary nocardiosis in Zhonghua Linchuang Ganranbing Zazhi (Chinese Journal of Clinical Infectious Diseases).
  • 2018Published case series on percutaneous lung biopsy in intensive care unit patients in Zhongguo Shiyong Neike Zazhi (Chinese Journal of Practical Internal Medicine); published case report on exogenous lipid pneumonia in Beijing Daxue Xuebao (Yixue Ban) (Journal of Peking University Health Sciences); published review on pulmonary nocardiosis with Aspergillus co-infection in Zhongguo Huxi Yu Weizhong Jianhu Zazhi (Chinese Journal of Respiratory and Critical Care Medicine).
  • 2019Co-authored case report on fatal community-acquired Pseudomonas aeruginosa pneumonia in Zhonghua Jiehe He Huxi Zazhi (Chinese Journal of Tuberculosis and Respiratory Diseases).
  • 2020Published study on SARS-CoV-2 and influenza A virus co-infection in Emerging Infectious Diseases.
  • 2021Published study on pathogen distribution in severe community-acquired pneumonia among immunocompromised patients in Zhonghua Jiehe He Huxi Zazhi; contributed to metagenomic next-generation sequencing research for pathogen diagnosis in Frontiers in Cellular and Infection Microbiology; contributed to lung microbiota research in Frontiers in Medicine.

Experience & recognition

  • PhD from Peking University Health Science Center
  • Visiting scholar at Keck School of Medicine, University of Southern California
  • Certified PCCM specialist by Chinese Thoracic Society (CTS) and American College of Chest Physicians (ACCP)
  • Principal author or co-author of six clinical guidelines/expert consensus documents
  • Contributor to multiple textbooks and professional reference books

Professional roles

  • Member, Chinese Medical Association (CMA)

Frequently asked questions

What does Dr. Wu Xiaojing specialize in?

Main clinical focus includes pulmonary infection, pneumonia in immunocompromised hosts, pulmonary nodules, COPD, asthma, bronchiectasis, interstitial lung disease, and lung cancer; main research focus is mechanisms of severe pneumonia and bloodstream infection.

Which hospital and department is Dr. Wu Xiaojing in?

Department of Respiratory and Critical Care Medicine at China-Japan Friendship Hospital

Sources

Dr. Wu Xiaojing has not reviewed this page.